U.S. Non-Invasive Prenatal Testing Market Analysis 2020-2027 by Latest Technology, Top Companies, Emerging Trends, Future Growth Opportunities
The MarketWatch News Department was not involved in the creation of this content.
Nov 25, 2020 (AmericaNewsHour) —
The Centers for Medicare & Medicaid Services reported that the U.S health care spending grew 3.9% in 2017, reaching $3.5 trillion or $10,739 per person. This rise in healthcare expenditure across the nation is expected to boost the high-end healthcare diagnostic and treatment procedures and technologies, in-turn propelling the non-invasive prenatal testing market during the forecast period.
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”
Request to Fill the Form to Get Sample Copy of This Report: https://www.kennethresearch.com/sample-request-10166491
The US holds around 84% of the market share of the NIPT market in North America majorly due to its dominating share in the healthcare industry in 2018. Presence of major market players across the U.S such as, Natera Inc., Illumina Inc., Laboratory Corporation of